Emmanuel Pham

1.5k total citations
16 papers, 720 citations indexed

About

Emmanuel Pham is a scholar working on Neurology, Emergency Medicine and Molecular Biology. According to data from OpenAlex, Emmanuel Pham has authored 16 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Emergency Medicine and 3 papers in Molecular Biology. Recurrent topics in Emmanuel Pham's work include Botulinum Toxin and Related Neurological Disorders (4 papers), Cardiac Arrest and Resuscitation (4 papers) and Poisoning and overdose treatments (3 papers). Emmanuel Pham is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (4 papers), Cardiac Arrest and Resuscitation (4 papers) and Poisoning and overdose treatments (3 papers). Emmanuel Pham collaborates with scholars based in France, Belgium and United States. Emmanuel Pham's co-authors include Paul Petit, Pierre-Yves Dubien, Pierre‐Yves Gueugniaud, Patrick Goldstein, Pierre Carli, Michel Vergnion, Pierre Mols, Sigrid Nikol, Michael G. Wyatt and Dominique Stéphan and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Emmanuel Pham

16 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Pham France 11 296 244 177 116 113 16 720
V. Bogner Germany 14 312 1.1× 154 0.6× 109 0.6× 65 0.6× 119 1.1× 39 667
Tag Heo South Korea 12 297 1.0× 162 0.7× 52 0.3× 89 0.8× 58 0.5× 49 548
Yusuke Sawada Japan 13 133 0.4× 127 0.5× 77 0.4× 40 0.3× 72 0.6× 79 570
Kyu-Sun Choi South Korea 18 164 0.6× 194 0.8× 52 0.3× 89 0.8× 465 4.1× 68 904
P Tibbles United States 4 106 0.4× 182 0.7× 191 1.1× 31 0.3× 86 0.8× 5 876
Robert A. van Hulst Netherlands 16 122 0.4× 113 0.5× 60 0.3× 76 0.7× 205 1.8× 55 809
Jason Hayes Canada 17 79 0.3× 248 1.0× 112 0.6× 30 0.3× 33 0.3× 38 722
C Skrabal Germany 15 81 0.3× 489 2.0× 90 0.5× 275 2.4× 40 0.4× 28 879
Paul D. Weyker United States 13 50 0.2× 311 1.3× 54 0.3× 46 0.4× 76 0.7× 25 494
Christoph E. Heyde Germany 19 111 0.4× 633 2.6× 164 0.9× 53 0.5× 265 2.3× 40 1.1k

Countries citing papers authored by Emmanuel Pham

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Pham more than expected).

Fields of papers citing papers by Emmanuel Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Pham. The network helps show where Emmanuel Pham may publish in the future.

Co-authorship network of co-authors of Emmanuel Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Pham. A scholar is included among the top collaborators of Emmanuel Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Pham. Emmanuel Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pham, Emmanuel, et al.. (2023). In Silico Clinical Trials: Is It Possible?. Methods in molecular biology. 2716. 51–99. 9 indexed citations
2.
Boissel, Jean‐Pierre, et al.. (2022). Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?. SHILAP Revista de lepidopterología. 4. 810315–810315. 4 indexed citations
3.
Delafont, Bruno, Kevin Carroll, Claire Vilain, & Emmanuel Pham. (2018). Investigation of mixed model repeated measures analyses and non‐linear random coefficient models in the context of long‐term efficacy data. Pharmaceutical Statistics. 17(5). 515–526. 2 indexed citations
4.
Poewe, Werner, Pierre Burbaud, Giovanni Castelnovo, et al.. (2016). Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized‐controlled trial. Movement Disorders. 31(11). 1649–1657. 31 indexed citations
5.
Delgado, Mauricio R., Ann Tilton, Barry S. Russman, et al.. (2016). AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial. PEDIATRICS. 137(2). e20152830–e20152830. 54 indexed citations
6.
Cauchy, Emmanuel, et al.. (2016). Iloprost With and Without rt-PA: Treatment of 131 Cases of Severe Frostbite. Wilderness and Environmental Medicine. 27(3). 432–432. 1 indexed citations
7.
Prokosch, Verena, Tobias Stupp, Kristina Spaniol, Emmanuel Pham, & Sigrid Nikol. (2014). Angiogenic gene therapy does not cause retinal pathology. The Journal of Gene Medicine. 16(9-10). 309–316. 1 indexed citations
8.
Clayton, Peter, Mireille Bonnemaire, Pascal Maisonobe, et al.. (2013). Characterizing Short Stature by Insulin-like Growth Factor Axis Status and Genetic Associations: Results From the Prospective, Cross-sectional, Epidemiogenetic EPIGROW Study. The Journal of Clinical Endocrinology & Metabolism. 98(6). E1122–E1130. 21 indexed citations
9.
Behr‐Roussel, Delphine, S. Oger, Bernadette Pignol, et al.. (2012). Minimal Effective Dose of Dysport and Botox in a Rat Model of Neurogenic Detrusor Overactivity. European Urology. 61(5). 1054–1061. 30 indexed citations
10.
Nikol, Sigrid, Iris Baumgärtner, Éric Van Belle, et al.. (2008). Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia. Molecular Therapy. 16(5). 972–978. 216 indexed citations
11.
David, Jean, Pierre‐Yves Gueugniaud, Bruno Riou, et al.. (2007). Does the prognosis of cardiac arrest differ in trauma patients?*. Critical Care Medicine. 35(10). 2251–2255. 44 indexed citations
12.
Pham, Emmanuel, et al.. (2000). Validation Assessment of a French Version of the Tinnitus Reaction Questionnaire. Journal of Speech Language and Hearing Research. 43(1). 184–190. 13 indexed citations
13.
Gueugniaud, Pierre‐Yves, Pierre Mols, Patrick Goldstein, et al.. (1999). A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital. Survey of Anesthesiology. 43(5). 305–305. 24 indexed citations
14.
Gueugniaud, Pierre‐Yves, Pierre Mols, Patrick Goldstein, et al.. (1998). A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital. New England Journal of Medicine. 339(22). 1595–1601. 194 indexed citations
15.
Gueugniaud, P.-Y., et al.. (1995). Standard doses versus repeated high doses of epinephrine in cardiac arrest outside the hospital. Resuscitation. 29(1). 3–9. 62 indexed citations
16.
Tubert‐Jeannin, Stéphanie, et al.. (1994). Factors affecting caries experience in French adolescents. Community Dentistry And Oral Epidemiology. 22(1). 30–35. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026